# KPTIQ (Karyopharm Therapeutics Inc.) - SEC EDGAR Financial Statements

> Karyopharm Therapeutics Inc. reported $146.6M in revenue and a net loss of $224.7M for the trailing twelve months ended June 30, 2026 (down 11.9% year over year), with a -56.2% operating margin.

- Canonical: https://convexityos.com/fundamentals/KPTIQ
- Markdown: https://convexityos.com/fundamentals/KPTIQ.md
- SEC CIK: 0001503802
- Reporting currency: USD
- Latest filing period: June 30, 2026
- Last synced: Nov 21, 2026, 05:15 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001503802&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $146.6M | -11.9% YoY |
| Operating Income | TTM | -$82.35M | -56.2% margin |
| Net Income | TTM | -$224.7M | -153.3% net margin |
| Diluted EPS | TTM | -$7,766.26 | Split-adjusted |
| Free Cash Flow | TTM | -$75.37M | -51.4% FCF margin |
| Cash & ST Investments | Jun 30, 2026 | $65.11M | Total debt: $6.25M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $146.1M | $145.2M | $146.0M | $157.1M | $209.8M | $108.1M | $40.89M | $30.34M | $1.60M | $154K |
| Research & Development | $125.6M | $143.2M | $138.8M | $148.7M | $160.8M | $150.8M | $122.3M | $161.4M | $107.3M | $86.94M |
| Selling, General & Admin | $105.2M | $115.4M | $131.9M | $145.4M | $143.8M | $126.4M | $105.4M | $48.85M | $24.87M | -- |
| Total Operating Expenses | $236.8M | $264.7M | $275.6M | $299.3M | $308.1M | $279.9M | $230.2M | $210.2M | $132.1M | $110.9M |
| **Operating Income** | -$90.71M | -$119.4M | -$129.5M | -$142.2M | -$98.27M | -$171.8M | -$189.3M | -$179.9M | -$130.5M | -$110.7M |
| **EBITDA** | -$90.41M | -$119.1M | -$129.0M | -$141.6M | -$97.48M | -$170.9M | -$188.3M | -$179.1M | -$129.8M | -$110.0M |
| Interest Income | $2.77M | $7.40M | $10.94M | $2.36M | $582K | $2.82M | $5.42M | $4.03M | $1.70M | $1.28M |
| Interest Expense | $45.85M | $37.42M | $23.82M | $25.00M | $26.05M | $27.14M | $15.65M | $2.49M | -- | -- |
| Income Before Tax | -$196.0M | -$76.36M | -$142.8M | -$164.9M | -$123.8M | -$196.0M | -$199.6M | -$178.4M | -$128.9M | -$109.4M |
| Income Tax Expense | $43K | $57K | $323K | $369K | $268K | $309K | $40K | $26K | $63K | $139K |
| **Net Income** | -$196.0M | -$76.42M | -$143.1M | -$165.3M | -$124.1M | -$196.3M | -$199.6M | -$178.4M | -$129.0M | -$109.6M |
| Basic EPS | -$17.93 | -$9.41 | -$18.79 | -$30.30 | -$24.75 | -$40.80 | -$48.30 | -$47.10 | -$42.15 | -$43.80 |
| **Diluted EPS** | -$17.93 | -$14.00 | -$18.79 | -$30.30 | -$24.75 | -$40.80 | -$48.30 | -$47.10 | -$42.15 | -$43.80 |
| Basic Shares Outstanding | 10.9K | 8.1K | 7.6K | 5.5K | 5.0M | 4.8M | 4.1M | 3.8K | 3.1M | 2.5M |
| Diluted Shares Outstanding | 10.9K | 8.5K | 7.6K | 5.5K | 5.0M | 4.8M | 4.1M | 3.8K | 3.1M | 2.5M |

### Income Statement (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $33.43M | $35.07M | $34.08M | $44.04M | $37.93M | $30.02M | $30.54M | $38.78M |
| Research & Development | $28.96M | $33.80M | $27.67M | $30.54M | $32.79M | $34.62M | $33.30M | $36.13M |
| Selling, General & Admin | $25.92M | $26.68M | $22.77M | $26.61M | $28.48M | $27.35M | $27.19M | $27.63M |
| Total Operating Expenses | $55.96M | $61.83M | $51.92M | $59.26M | $62.32M | $63.27M | $61.82M | $65.07M |
| **Operating Income** | -$22.53M | -$26.76M | -$17.84M | -$15.22M | -$24.39M | -$33.26M | -$31.28M | -$26.28M |
| **EBITDA** | -$22.53M | -$26.75M | -$17.82M | -$15.10M | -$24.31M | -$33.18M | -$31.20M | -$26.20M |
| Interest Income | $722K | $511K | $607K | $553K | $613K | $1.00M | $1.48M | $1.83M |
| Interest Expense | $13.14M | $12.55M | $12.62M | $11.01M | $11.23M | $10.99M | $11.20M | $11.38M |
| Income Before Tax | -$67.02M | -$22.39M | -$102.3M | -$33.09M | -$37.21M | -$23.43M | -$30.89M | -$32.04M |
| Income Tax Expense | $0 | $1.0K | -$67K | $34K | $40K | $36K | -$109K | $28K |
| **Net Income** | -$67.02M | -$22.39M | -$102.2M | -$33.13M | -$37.25M | -$23.46M | -$30.78M | -$32.07M |
| Basic EPS | -$2.32 | -$1.02 | -- | -$3.82 | -$4.32 | -$2.77 | -- | -$3.85 |
| **Diluted EPS** | -$2.32 | -$1.24 | -- | -$3.82 | -$4.32 | -$2.77 | -- | -$3.85 |
| Basic Shares Outstanding | 28.9K | 22.0K | -- | 8.7K | 8.6K | 8.5K | -- | 8.3K |
| Diluted Shares Outstanding | 28.9K | 24.7K | -- | 8.7K | 8.6K | 8.5K | -- | 8.3K |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $60.54M | $62.48M | $52.23M | $135.2M | $190.5M | $85.92M | $128.9M | $118.0M | $69.00M | $49.66M |
| Short-Term Investments | $3.20M | $46.24M | $139.2M | $142.8M | $38.16M | $163.3M | $133.1M | $210.2M | $77.47M | $79.89M |
| **Cash & Short-Term Investments** | $63.70M | $108.7M | $191.4M | $278.0M | $228.6M | $249.2M | $262.0M | $328.2M | $146.5M | $129.6M |
| Accounts Receivable, Net | $26.18M | $30.77M | $26.96M | $47.09M | $22.50M | $12.88M | $7.86M | -- | -- | -- |
| Inventory | $4.04M | $4.74M | $3.04M | $4.22M | $4.11M | $2.64M | $346K | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | $1.53M | -- | -- | -- | -- | -- |
| **Total Current Assets** | $103.1M | $156.5M | $233.9M | $350.2M | $275.6M | $276.5M | $278.6M | $334.6M | $148.4M | $131.6M |
| Property, Plant & Equipment, Net | $104K | $400K | $606K | $1.14M | $1.64M | $2.22M | $3.05M | $3.86M | $2.19M | $2.84M |
| Long-Term Investments | -- | -- | -- | -- | -- | $24.21M | $2.02M | $2.00M | $29.40M | $45.43M |
| **Total Non-Current Assets** | $5.27M | $7.96M | $6.52M | $8.01M | $29.70M | $36.52M | $16.39M | $6.58M | $31.87M | $48.75M |
| **Total Assets** | $108.4M | $164.4M | $240.4M | $358.2M | $305.3M | $313.1M | $295.0M | $341.2M | $180.3M | $180.4M |
| Accounts Payable | $4.00M | $5.11M | $3.12M | $2.77M | $1.60M | $4.45M | $985K | $4.33M | $5.67M | $4.75M |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | $297K | $2.34M | $9.36M | $21.92M | -- |
| Other Current Liabilities | $1.58M | $1.64M | $1.65M | $1.85M | $678K | $609K | $500K | $327K | $133K | $83K |
| **Total Current Liabilities** | $92.06M | $92.26M | $69.48M | $65.91M | $73.72M | $60.20M | $46.35M | $46.90M | $49.47M | $16.48M |
| Long-Term Debt | -- | -- | -- | -- | $169.3M | -- | -- | -- | -- | -- |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | $0 | $2.19M | $4.53M | -- | -- |
| Other Non-Current Liabilities | $11.10M | $2.43M | $978K | $0 | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $309.3M | $258.2M | $307.2M | $308.9M | $311.3M | $202.3M | $198.8M | $111.1M | $1.36M | $1.67M |
| **Total Liabilities** | $401.3M | $350.4M | $376.6M | $374.8M | $385.0M | $262.5M | $245.2M | $158.0M | $50.83M | $18.14M |
| **Total Debt (incl. Leases)** | $6.71M | $7.15M | $6.10M | $8.97M | $180.6M | $13.20M | $14.85M | -- | -- | -- |
| Common Stock | $14K | $13K | $12K | $12K | $8.0K | $7.0K | $7.0K | $6.0K | $5.0K | $4.0K |
| Retained Earnings | -$1.76B | -$1.56B | -$1.49B | -$1.34B | -$1.18B | -$1.07B | -$873.3M | -$673.7M | -$495.3M | -$366.1M |
| Accumulated Other Comp. Income | $71K | -$356K | -$161K | -$638K | $191K | $518K | -$37K | -$244K | -$217K | -$274K |
| **Total Stockholders' Equity** | -$292.9M | -$186.0M | -$136.2M | -$16.66M | -$79.67M | $50.55M | $49.77M | $183.2M | $129.5M | $162.2M |
| Total Equity | -$292.9M | -$186.0M | -$136.2M | -$16.66M | -$79.67M | $50.55M | $49.77M | $183.2M | $129.5M | $162.2M |

### Balance Sheet (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $54.98M | $90.85M | $60.54M | $37.67M | $38.73M | $38.78M | $62.48M | $72.83M |
| Short-Term Investments | $10.12M | $0 | $3.20M | $8.21M | $12.97M | $31.16M | $46.24M | $60.70M |
| **Cash & Short-Term Investments** | $65.10M | $90.90M | $63.70M | $45.90M | $51.70M | $69.90M | $108.7M | $133.5M |
| Accounts Receivable, Net | $29.87M | $23.36M | $26.18M | $31.88M | $32.93M | $35.24M | $30.77M | $31.78M |
| Inventory | $3.99M | $3.60M | $4.04M | $3.97M | $4.99M | $4.77M | $4.74M | $4.67M |
| **Total Current Assets** | $106.4M | $126.3M | $103.1M | $89.75M | $97.87M | $120.2M | $156.5M | $184.8M |
| Property, Plant & Equipment, Net | $94K | $91K | $104K | $122K | $244K | $322K | $400K | $495K |
| **Total Non-Current Assets** | $4.94M | $5.08M | $5.27M | $6.49M | $7.01M | $7.47M | $7.96M | $4.72M |
| **Total Assets** | $111.3M | $131.4M | $108.4M | $96.23M | $104.9M | $127.7M | $164.4M | $189.5M |
| Accounts Payable | $7.66M | $4.28M | $4.00M | $5.39M | $2.60M | $5.87M | $5.11M | $5.78M |
| Other Current Liabilities | $6.39M | $3.47M | $1.58M | $1.76M | $1.57M | $1.94M | $1.64M | $1.94M |
| **Total Current Liabilities** | $134.2M | $117.3M | $92.06M | $87.16M | $99.22M | $90.37M | $92.26M | $61.49M |
| Other Non-Current Liabilities | $336K | $278K | $11.10M | $14.12M | $8.26M | $5.15M | $2.43M | $6.18M |
| **Total Non-Current Liabilities** | $307.3M | $279.8M | $309.3M | $278.3M | $244.6M | $243.2M | $258.2M | $287.6M |
| **Total Liabilities** | $441.5M | $397.1M | $401.3M | $365.5M | $343.8M | $333.6M | $350.4M | $349.1M |
| **Total Debt (incl. Leases)** | $6.25M | $6.49M | $6.71M | $6.93M | $7.63M | $7.41M | $7.15M | $3.67M |
| Common Stock | $14K | $14K | $14K | $13K | $13K | $13K | $13K | $13K |
| Retained Earnings | -$1.85B | -$1.78B | -$1.76B | -$1.66B | -$1.62B | -$1.59B | -$1.56B | -$1.53B |
| Accumulated Other Comp. Income | $41K | $43K | $71K | -$259K | -$251K | -$321K | -$356K | -$222K |
| **Total Stockholders' Equity** | -$330.2M | -$265.6M | -$292.9M | -$269.3M | -$238.9M | -$205.9M | -$186.0M | -$159.6M |
| Total Equity | -$330.2M | -$265.6M | -$292.9M | -$269.3M | -$238.9M | -$205.9M | -$186.0M | -$159.6M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$196.0M | -$76.42M | -$143.1M | -$165.3M | -$124.1M | -$196.3M | -$199.6M | -$178.4M | -$129.0M | -$109.6M |
| Depreciation & Amortization | $296K | $340K | $530K | $621K | $789K | $972K | $974K | $735K | $713K | $717K |
| Stock-Based Compensation | $14.05M | $18.43M | $21.71M | $35.40M | $29.78M | $24.41M | $15.29M | $17.27M | $20.41M | $22.28M |
| Change in Receivables | $4.59M | -$3.80M | $20.12M | -$5.08M | -$9.62M | -$5.02M | -$7.86M | -- | -- | -- |
| Change in Inventory | $701K | -$1.70M | $1.18M | -$118K | -$1.46M | -$2.63M | -$346K | -- | -- | -- |
| Change in Payables | -$1.10M | $1.98M | $350K | $1.17M | -$2.85M | $3.46M | -$3.30M | -$1.38M | $909K | $945K |
| **Operating Cash Flow** | -$75.37M | -$127.5M | -$92.72M | -$149.6M | -$107.1M | -$160.2M | -$190.8M | -$159.1M | -$73.72M | -$84.39M |
| Capital Expenditure | $0 | -$142K | $0 | -$118K | -$212K | -$145K | -$206K | -$2.36M | -$62K | -$70K |
| **Free Cash Flow** | -$75.37M | -$127.6M | -$92.72M | -$149.7M | -$107.3M | -$160.4M | -$191.0M | -$161.5M | -$73.78M | -$84.46M |
| Purchases of Investments | $0 | -$58.82M | -$159.2M | -$226.0M | -$45.23M | -$274.6M | -$178.5M | -$242.8M | -$98.37M | -$134.7M |
| Sales & Maturities of Investments | -- | -- | -- | -- | -- | -- | -- | -- | $115.5M | $159.4M |
| **Investing Cash Flow** | $43.38M | $95.47M | $7.94M | -$104.3M | $141.8M | -$53.69M | $78.45M | -$107.7M | $17.11M | $24.59M |
| **Financing Cash Flow** | $30.05M | $41.65M | $1.12M | $193.7M | $73.65M | $172.1M | $124.3M | $316.1M | $75.74M | $51.16M |
| **Net Change in Cash** | -$1.92M | $9.62M | -$83.69M | -$60.56M | $108.3M | -$41.57M | $11.95M | $49.25M | $19.34M | -$8.70M |

### Cash Flow Statement (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$67.02M | -$22.39M | -$102.2M | -$33.13M | -$37.25M | -$23.46M | -$30.78M | -$32.07M |
| Depreciation & Amortization | -$3.0K | $12K | $19K | $121K | $78K | $78K | $81K | $83K |
| Stock-Based Compensation | $1.93M | $3.01M | $3.90M | $2.80M | $3.78M | $3.56M | $3.86M | $4.18M |
| Change in Receivables | -$6.51M | $2.82M | $5.70M | $1.05M | $2.31M | -$4.48M | $1.01M | $6.22M |
| Change in Inventory | -$395K | $439K | -$72K | $1.03M | -$223K | -$30K | -$67K | -$1.20M |
| Change in Payables | $3.38M | $276K | -$1.39M | $2.79M | -$3.27M | $765K | -$676K | $2.99M |
| **Operating Cash Flow** | -$24.93M | -$22.73M | -$11.83M | -$5.86M | -$18.70M | -$38.98M | -$25.81M | -$19.45M |
| Capital Expenditure | -- | -- | $0 | $0 | $0 | $0 | $53K | $0 |
| **Free Cash Flow** | -- | -- | -$11.83M | -$5.86M | -$18.70M | -$38.98M | -$25.76M | -$19.45M |
| Purchases of Investments | -- | -- | $0 | $0 | $0 | $0 | -$1.51M | -$20.80M |
| **Investing Cash Flow** | -$10.04M | $3.20M | $5.00M | $4.80M | $18.29M | $15.29M | $14.80M | $7.47M |
| Common Stock Issued | $0 | $20.23M | -- | -- | $0 | $0 | -- | -- |
| **Financing Cash Flow** | -$898K | $49.80M | $29.69M | $0 | $356K | $0 | -- | -- |
| **Net Change in Cash** | -$35.87M | $30.28M | $22.87M | -$1.05M | -$48K | -$23.69M | -$10.35M | -$11.94M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -62.1% | -82.2% | -88.7% | -90.5% | -46.8% | -159.0% | -462.9% | -593.0% | -8133.2% | -71903.9% |
| **Net Profit Margin** | -134.2% | -52.6% | -98.0% | -105.2% | -59.1% | -181.6% | -488.1% | -588.1% | -8036.4% | -71153.9% |
| Return on Equity (ROE) | -- | -- | -- | -- | -- | -388.3% | -401.0% | -97.4% | -99.6% | -67.5% |
| Return on Assets (ROA) | -180.8% | -46.5% | -59.5% | -46.1% | -40.6% | -62.7% | -67.7% | -52.3% | -71.5% | -60.7% |
| Current Ratio | 1.12x | 1.70x | 3.37x | 5.31x | 3.74x | 4.59x | 6.01x | 7.13x | 3.00x | 7.99x |
| Quick Ratio | 1.08x | 1.64x | 3.32x | 5.25x | 3.68x | 4.55x | 6.00x | 7.00x | 2.96x | 7.86x |
| Debt to Equity | -- | -- | -- | -- | -- | 0.26x | 0.30x | -- | -- | -- |
| **Revenue Growth (YoY)** | +0.6% | -0.5% | -7.0% | -25.1% | +94.1% | +164.3% | +34.8% | +1790.1% | +942.2% | -38.4% |
| 5Y Revenue / Share Growth | +59257.3% | +180446.9% | +139.2% | +5486650.0% | +67867.4% | +21275.5% | +8874.2% | +837647.0% | -90.2% | -97.3% |
| 10Y Revenue / Share Growth | +12687807.3% | +16202537.8% | +2004116.0% | +537139.7% | +1742.8% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -56.2% | -55.7% | -62.1% | -73.1% | -83.9% | -83.7% | -82.2% | -84.9% |
| **Net Profit Margin** | -153.3% | -129.0% | -134.2% | -87.4% | -90.0% | -44.0% | -52.6% | -58.9% |
| Return on Assets (ROA) | -201.9% | -148.4% | -180.8% | -129.5% | -117.8% | -49.0% | -46.5% | -46.2% |
| Current Ratio | 0.79x | 1.08x | 1.12x | 1.03x | 0.99x | 1.33x | 1.70x | 3.00x |
| Quick Ratio | 0.76x | 1.05x | 1.08x | 0.98x | 0.94x | 1.28x | 1.64x | 2.93x |
| **Revenue Growth (YoY)** | -11.9% | +16.8% | +11.6% | +13.6% | -11.4% | -9.4% | -9.5% | +7.7% |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -256.6% | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -112.7% | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
